e mbryo adopt i on
play

E MBRYO ADOPT I ON Re pro duc tive T e c hno lo g y, I - PowerPoint PPT Presentation

E MBRYO ADOPT I ON Re pro duc tive T e c hno lo g y, I n-Vitro F e rtiliza tio n, a nd Whe the r Christia ns Sho uld Ado pt E mb ryo s 1. De fine T e rms 2. Sta tistic s/ Histo ry 3. Pub lic Po lic y 4. Mo st impo rta


  1. E MBRYO ADOPT I ON Re pro duc tive T e c hno lo g y, I n-Vitro F e rtiliza tio n, a nd Whe the r Christia ns Sho uld Ado pt E mb ryo s

  2.  1. De fine T e rms  2. Sta tistic s/ Histo ry  3. Pub lic Po lic y  4. Mo st impo rta ntly – Se a rc h the Sc ripture s  5. Christia n E thic s  6. Pa sto ra l Ca re a nd Pra c tic e  7. Que stio ns, Co mme nts, Co nc e rns, Disc ussio n WHY?

  3.  “Re pro duc tive T e c hno lo g y e nc o mpa sse s a ll c urre nt a nd a ntic ipa te d use s o f te c hno lo g y in huma n a nd a nima l re pro duc tio n, inc luding a ssiste d re pro duc tive te c hno lo g y, c o ntra c e ptio n a nd o the rs.” T E RMS: RE PRODUCT I VE T E CHNOL OGY

  4.  Assiste d Re pro duc tive T e c hno lo g y tre a ts infe rtility a nd inc lude s:  Artific ia l inse mina tio n  Clo ning  Cyto pla smic T ra nsfe r  Cryo pre se rva tio n o f spe rm, o o c yte s, e mb ryo s  E mb ryo tra nsfe r  F e rtility me dic a tio n  Ho rmo ne tre a tme nt  I n Vitro F e rtiliza tio n  I n Vitro g e ne ra te d g a me te s  Pre impla nta tio n g e ne tic dia g no sis T E RMS: ASSI ST E D RE PRODUCT I VE T E CHNOL OGY

  5.  “F uture c ha nc e s o f pre g na nc y, fa c ilita ting a n info rme d c ho ic e o f fa mily pla nning ”  Ma pping a wo ma n’ s o va ria n re se rve , fo llic ula r dyna mic s, a nd a sso c ia te d b io ma rke rs  Se me n a na lysis T E RMS: PROGNOST I CS

  6.  “A fo rm o f re pro duc tive te c hno lo g y tha t e na b le s pe o ple to c o ntro l the ir fe rtility” T E RMS: CONT RACE PT I ON

  7.  Artific ia l wo mb s: “a t the de ve lo pme nta l sta g e ”  Ge rmina l c ho ic e te c hno lo g y = g e ne tic sc re e ning o f b la sto c ysts (e a rly e mb ryo s), o r g e rmline e ng ine e ring (huma n g e ne tic e ng ine e ring use d to a lte r g e ne s in the first c e lls o f the b la sto c yst)  I n Vitro Pa rthe no g e ne sis = spe rm trig g e rs the de ve lo pme nt o f the e g g c e ll into a n e mb ryo b ut ma ke s no g e ne tic c o ntrib utio n to the e mb ryo  Re pro g e ne tic s = “the use o f re pro duc tive a nd g e ne tic te c hno lo g ie s to se le c t a nd g e ne tic a lly mo dify e mb ryo s with g e rmina l c ho ic e te c hno lo g y fo r the purpo se o f huma n e nha nc e me nt”  Sa me -se x pro c re a tio n = fe ma le spe rm (c o nta ins a n X c hro mo so me ) o r ma le e g g s (fe ma le e g g s e mptie d o f g e ne tic c o nte nts a nd re pla c e d with ma le DNA), whe re two me n o r two wo me n c a n ha ve a c hild with e q ua l g e ne tic c o ntrib utio ns fro m b o th me n o r b o th wo me n T E RMS: OT HE R ASSI ST E D RE PRODUCT I VE T E CHNOL OGI E S

  8.  E g g c e ll = fe ma le re pro duc tive c e ll (g a me te ) = Ovum = o o c yte (imma ture o vum o r e g g c e ll)  Visib le to the na ke d e ye , a b o ut 0.12mm in dia me te r  K no wn a s “o va ” in a nima ls  Ova ry (L a tin: “e g g ” o r “nut”) = o vum-pro duc ing fe ma le re pro duc tive o rg a n  Usua lly, o vula tio n o c c urs in o ne o f two o va rie s, re le a sing a fe rtiliza b le e g g e a c h me nstrua l c yc le  Ova ria n F o llic le = se c re te s ho rmo ne s tha t re le a se a n e g g c e ll a t o vula tio n fo r fe rtiliza tio n T E RMS: E GG, OVUM, OOCYT E ; OVARY, OVUL AT I ON, OVARI AN F OL L I CL E

  9.  T e ste s = spe rm-pro duc ing ma le re pro duc tive o rg a n  Spe rm (“se e d”) = ma le re pro duc tive c e ll (g a me te )  Spe rma to zo a (“se e d” + “living b e ing ”) = 60 da y fully ma ture  Se me n = fluid tha t ma y c o nta in spe rma to zo a  Se me n Qua lity = me a sure o f the a b ility o f se me n to a c c o mplish fe rtiliza tio n; ma le fe rtility – spe rm c o unt (usua lly 300-500 millio n spe rma to zo a o f typic a l he a lthy, physic a lly ma ture yo ung a dult ma le o f re pro duc tive a g e )  I nse mina tio n = “de lib e ra te intro duc tio n o f spe rm into a fe ma le fo r the purpo se o f impre g na ting o r fe rtilizing the fe ma le fo r se xua l re pro duc tio n” T E RMS: T E ST E S, SPE RM, SE ME N, I NSE MI NAT I ON

  10.  F e rtiliza tio n = (a lso kno wn a s c onc e ption ) is the fusio n o f g a me te s to initia te the de ve lo pme nt o f a ne w individua l o rg a nism  Zyg o te (“to jo in, to yo ke ”) = fe rtilize d c e ll o f 2 g a me te s (1 e g g , 1 spe rm)  E mb ryo (“yo ung o ne ;” “g ro wing in”) = 1 (o r 3) we e k o ld, multi-c e llula r, fro m zyg o te sta g e to 8 we e ks (56 da ys)  Bla sto c yst (“put fo rth sho o ts;” “c a psule ”) = fro m 5 da ys a fte r fe rtiliza tio n, until 11 o r 12 whe n impla nte d in ute rine wa ll  F e tus (L a t. “o ffspring ”) = is a pre na ta l huma n (!) b e twe e n its e mb ryo nic sta te a nd its b irth; 11 we e ks g e sta tio n, 9 we e ks a fte r fe rtiliza tio n T E RMS: F E RT I L I ZAT I ON, ZYGOT E , E MBRYO, BL AST OCYST , F E T US

  11.  I n Vitro F e rtiliza tio n (I VF) = pla c ing o ne e g g in a sma ll ro und g la ss dish a nd smo the ring it with spe rm c e lls unto o ne pe ne tra te s a nd fe rtilize s the e g g to pro duc e the zyg o te ; ma y ta ke up to 30hrs  Dire c t E g g Spe rm I nje c tio n (DE SI ) = spe rm a nd e g g s a re c o lle c te d sa me wa y a s I VF ; he re o ne e g g is dire c tly inje c te d with o ne spe rm c e ll; if it wo rks, fe rtiliza tio n o c c urs within se ve ra l ho urs  1. Ova ria n stimula tio n (supe ro vula to ry drug s suc h a s L upro n o r Clo miphe ne Citra te )  2. Six to T we nty-two o o c yte s a re re c o ve re d, c le a ne d, a nd re a die d fo r I VF o r fo r DE SI  3. Spe rm o f the husb a nd is re c o ve re d via ma sturb a tio n o r a spira tio n o f g o na d tissue s; spe rm a re c le a ne d a nd c o unte d. T ho se tha t a re the mo st mo b ile a nd in “g o o d sha pe ” a re c le a ne d a nd ke pt fo r fe rtiliza tio n  4. E mb ryo s g ra de d fo r the suita b ility fo r impla nta tio n & fre e zing T E RMS: I N VI T RO F E RT I L I ZAT I ON, DI RE CT E GG SPE RM I NJE CT I ON

  12.  Cryo pre se rva tio n = pre se rve d b y c o o ling to sub -ze ro te mpe ra ture s, fre e zing in liq uid nitro g e n to -321.0 F ; de ve lo pe d in la te 1970s  L o ng e st re po rte d suc c e ssful sto ra g e with se me n c ryo pre se rva tio n is 21 ye a rs  7%-57% o f tha we d huma n e mb ryo s die in the ra pid tha wing pro c e ss  Cryo pre se rva tio n is suppo se d to re duc e the risk o f ma jo r multiple pre g na nc ie s, inc re a se the numb e r o f e mb ryo tra nsfe rs, a nd, he nc e , pre g na nc ie s pe r stimula tio n a nd re trie va l c yc le , a vo id Ova ria n Hype rStimula tio n Syndro me , pre se rve future c hild- b e a ring c a pa b ility in wo me n fa c ing o va ria n surg e ry o r c a nc e r the ra py, a nd re duc e pa tie nt e xpe nse a nd risk fro m a dditio na l stimula tio n a nd re trie va l c yc le s T E RMS: CRYOPRE SE RVAT I ON

  13.  Surro g a c y = a rra ng e me nt o r a g re e me nt to c a rry a pre g na nc y fo r inte nde d pa re nts  Ge sta tio na l Surro g a c y = E mb ryo tra nsfe r c re a te d thro ug h I VF , so tha t the c hild is g e ne tic a lly unre la te d to the surro g a te  T ra ditio na l Surro g a c y = Surro g a te is impre g na te d na tura lly o r a rtific ia lly, b ut the re sulting c hild is g e ne tic a lly re la te d to the surro g a te  OR, is surro g a c y a ny “sub stitute ? ” T E RMS: SURROGACY

  14.  “E mb ryo do na tio n is a pro c e ss b y whic h c o uple s who ha ve c ryo g e nic a lly pre se rve d e mb ryo s re linq uish a ny a nd a ll le g a l rig hts to tho se e mb ryo s a nd g ive the m to a no the r c o uple with no g e ne tic tie s to the e mb ryo s.” T E RMS: E MBRYO ADOPT I ON

  15.  July 25 1978 – 1 st “te st tub e ” (a c tua lly pe tri dish) b a b y, L o uise Bro wn, b o rn in Oldha m, E ng la nd, 5lb s., 12o z.  1983 – 1 st pre g na nc y fro m a c ryo pre se rve d 8-c e ll e mb ryo (te rmina te d a t 24 we e ks)  1986 – 1 st live b irth in the Unite d Sta te s fro m a n in vitro fe rtilize d o o c yte sub se q ue ntly c ryo pre se rve d, sto re d, tha we d, a nd the n tra nsfe rre d to the ute rus o f the g e ne tic o o c yte do no r  1990 – Unite d K ing do m Pa rlia me nt rule s tha t g a me te s o r e mb ryo s sha ll no t b e sto re d fo r mo re tha n 10 o r 5 ye a rs, re spe c tive ly  1996 – Up to 6,000 British e mb ryo s de stro ye d (murde re d ) b e c a use pa re nts no lo ng e r wa nte d the m o r pa re nts c o uldn’ t b e fo und  I n re spo nse the Va tic a n pub lishe d re spo nse a sking ma rrie d wo me n to b ring a b a ndo ne d e mb ryo s to te rm: “pre na ta l a do ptio n” ST AT I ST I CS/ HI ST ORY

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend